FIBROBIOLOGICS INC (FBLG) Stock Cash Flow
NASDAQ:FBLG - US31573L1052 - Common Stock
0.62 USD
+0.02 (+3.37%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.22M | -11.16M | -16.48M | -5.12M | -1.58M | |||
| Depreciation Amortization | 868.00K | 573.00K | 437.00K | N/A | N/A | |||
| Change In Working Capital | -2.36M | 559.00K | 493.00K | 307.00K | 172.00K | |||
| Interest Paid | 21.00K | 20.00K | 2.00K | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -226.00K | -1.87M | 9.15M | 748.00K | N/A | |||
| OPERATING CASH FLOW | -14.94M | -11.90M | -6.40M | -4.07M | -1.41M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -366.00K | -184.00K | -495.00K | N/A | N/A | |||
| INVESTING CASH FLOW | -366.00K | -184.00K | -495.00K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 13.49M | 9.40M | 300.00K | 3.77M | 1.52M | |||
| Stock Issued/Repurchased | N/A | 7.51M | 16.14M | 2.15M | N/A | |||
| Other Financing Activity | N/A | N/A | -2.65M | N/A | 292.00K | |||
| FINANCING CASH FLOW | 18.18M | 16.91M | 13.79M | 5.92M | 1.82M | |||
| CHANGE IN CASH | 2.87M | 4.82M | 6.90M | 1.86M | 407.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.94M | -11.90M | -6.40M | -4.07M | -1.41M | |||
| Capital Expenditure | -366.00K | -184.00K | -495.00K | N/A | N/A | |||
| FREE CASH FLOW | -15.30M | -12.09M | -6.90M | -4.07M | -1.41M | |||
All data in USD